๐ฐ Technologies Munich News
Technologies Munich News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Technologies Munich. Real-time updates on events, politics, business and more.
May 30, 2024
Bruce Power is doubling its capacity to produce its cancer-fighting medical isotopes. In partnership with Saug...
May 29, 2024
A second isotope production line is being installed at Bruce 7 to double its production capacity to meet forecast increases in demand. Bruce Power and Saugeen Ojibway Nation have also announced an expansion of their partnership for the production of and marketing of medical radioisotopes.
May 29, 2024
PORTLAND, Ore., May 29, 2024 /PRNewswire/ -- Allied Market Research published a report, titled, "Radiopharmaceuticals Market by End User (Hospitals and Clinics, Medical Imaging Centers, and
May 29, 2024
Bruce Power is doubling its capacity to produce its cancer-fighting medical isotopes. In partnership with Saugeen Ojibway Nation, Isogen, and ITM Isot...
February 1, 2024
License will support ITM’s efforts in preparing for the commercialization of its diagnostic and therapeutic radiopharmaceutical pipeline across the U.S.
January 16, 2024
Garching / Munich, Germany, January 16, 2024 โ ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced the...
January 4, 2024
Receipt of Radioactive Material Handling License (RAM License) for production of n.c.a. Lutetium-177Progress demonstrates company’s ability to rapidly increase GMP manufacturing capabilities to further supply growing demand for radiopharmaceuticals
January 4, 2024
Receipt of Radioactive Material Handling License (RAM License) for production of n.c.a. Lutetium-177Progress demonstrates company’s ability to rapidly increase GMP manufacturing capabilities to further supply growing demand for radiopharmaceuticals
January 4, 2024
Receipt of Radioactive Material Handling License (RAM License) for production of n.c.a. Lutetium-177Progress demonstrates companyโs ability to rapidly...
December 21, 2023
Garching / Munich, Germany, December 21, 2023 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced that CEO, Steffen Schuster and CFO, Dr. Klaus Maleck